Phase IIa Study of Single-Agent MOR208 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Year: 2015
Type: article
Study design: Clinical Trial
Source: Blood
Institutions: Jagiellonian University, University of Bologna, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Hackensack University Medical Center, Hospital Universitario Puerta de Hierro Majadahonda, Semmelweis University, Copernicus Memorial Hospital, Medical University of Lodz, The Ohio State University, Universität Ulm, University Hospital Ulm, MorphoSys (Germany), The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2521775567